JD Health International Inc

06618

Company Profile

  • Business description

    JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

  • Contact

    No. 20 Kechuang 11 Street
    Block C, Building 2, Jingdong Headquarters
    Economic and Technological Development Zone
    Daxing District
    Beijing101111
    CHN

    https://ir.jdhealth.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 December 2026

    Employees

    5,263

Stocks News & Analysis

stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.
stocks

Nvidia dominance continues

Our view on the latest earnings report.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,877.2015.00-0.17%
CAC 408,115.7529.750.37%
DAX 4024,888.56281.791.15%
Dow JONES (US)50,579.70294.040.58%
FTSE 10010,466.2622.790.22%
HKSE25,606.03219.510.86%
NASDAQ26,343.9750.870.19%
Nikkei 22563,339.071,654.932.68%
NZX 50 Index12,991.31113.240.88%
S&P 5007,473.4727.750.37%
S&P/ASX 2008,657.0015.10-0.17%
SSE Composite Index4,112.9035.620.87%

Market Movers